Daniel Goldberger Net Worth

The estimated Net Worth of Daniel S Goldberger is at least $3.29 Million dollars as of 5 June 2024. Mr. Goldberger owns over 38,505 units of ElectroCore Inc stock worth over $1,497,390 and over the last 9 years he sold ECOR stock worth over $0. In addition, he makes $1,789,430 as Chief Executive Officer and Director at ElectroCore Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Goldberger ECOR stock SEC Form 4 insiders trading

Daniel has made over 23 trades of the ElectroCore Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 38,505 units of ECOR stock worth $247,587 on 5 June 2024.

The largest trade he's ever made was exercising 53,764 units of ElectroCore Inc stock on 1 October 2021 worth over $322,584. On average, Daniel trades about 8,874 units every 78 days since 2015. As of 5 June 2024 he still owns at least 249,565 units of ElectroCore Inc stock.

You can see the complete history of Mr. Goldberger stock trades at the bottom of the page.

Daniel Goldberger biography

Daniel S. Goldberger serves as Chief Executive Officer, Director of the Company. He has served as the Company’s Chief Executive Officer and a member of the Board since October 1, 2019. From January 2018 to September 2019, Mr. Goldberger served as the Chief Executive Officer of Synergy Disc Replacement Inc., a private company commercializing a proprietary total disc implant for cervical spine therapy. Since April 2018, Mr. Goldberger has served as a director of KORU Medical Systems, Inc., a public medical device company with a focus on ambulatory infusion, where he has also held the positions of lead independent director, interim chief executive officer, and executive chairman. From July 2017 to September 2017, Mr. Goldberger served as chief executive officer of Milestone Medical, Inc. Prior to this he served as the chief executive officer of Xtant Medical Holdings, Inc. from August 2013 to January 2017. He also served as the chief executive officer of Sound Surgical Technologies LLC from April 2007 to February 2013. Mr. Goldberger also served on the boards of Xtant Medical Holdings, Inc., Sound Surgical, Xcorporeal and Glucon. He currently serves as an advisor to investment funds Meridian Capital and Wellfleet Capital. Mr. Goldberger earned a B.S. in Mechanical Engineering from The Massachusetts Institute of Technology, and a M.S. in Mechanical Engineering from Stanford University. The Board believes that Mr. Goldberger’s extensive senior management experience in the medical device industry, including as the Company’s Chief Executive Officer, qualify him for service on the Board.

What is the salary of Daniel Goldberger?

As the Chief Executive Officer and Director of ElectroCore Inc, the total compensation of Daniel Goldberger at ElectroCore Inc is $1,789,430. There are no executives at ElectroCore Inc getting paid more.

How old is Daniel Goldberger?

Daniel Goldberger is 61, he's been the Chief Executive Officer and Director of ElectroCore Inc since 2019. There are 6 older and 11 younger executives at ElectroCore Inc. The oldest executive at ElectroCore Inc is Peter Cuneo, 76, who is the Independent Director.

What's Daniel Goldberger's mailing address?

Daniel's mailing address filed with the SEC is 200 FORGE WAY, SUITE 205, , ROCKAWAY, NJ, 07866.

Insiders trading at ElectroCore Inc

Over the last 6 years, insiders at ElectroCore Inc have traded over $541,551 worth of ElectroCore Inc stock and bought 3,996,513 units worth $5,852,816 . The most active insiders traders include James L L Tullis, Joseph P Errico, and Thomas J. Errico. On average, ElectroCore Inc executives and independent directors trade stock every 38 days with the average trade being worth of $422,718. The most recent stock trade was executed by Thomas J. Errico on 15 August 2024, trading 5,000 units of ECOR stock currently worth $30,600.

What does ElectroCore Inc do?

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.

Complete history of Mr. Goldberger stock trades at Milestone Scientific, Xtant Medical Inc, ElectroCore Inc, and KORU Medical Systems Inc

ElectroCore Inc executives and stock owners

ElectroCore Inc executives and other stock owners filed with the SEC include:

• Daniel Goldberger,
  Chief Executive Officer, Director
• Joseph Errico,
  Director
• Brian Posner,
  Chief Financial Officer
• Daniel S. Goldberger,
  CEO & Director
• Brian M. Posner,
  CFO & Corp. Sec.
• Joseph P. Errico,
  Co-Founder, Principal Investor & Director
• Hans Vitzthum,
  Investor Relations
• Thomas Patton,
  Independent Director
• Stephen Ondra,
  Independent Director
• Trevor Moody,
  Independent Director
• John Gandolfo,
  Independent Director
• Thomas Errico,
  Independent Director
• Peter Cuneo,
  Independent Director
• Sylvester Steele,
  Vice President, General Manager of the Government Channels Business Unit
• Eric Liebler,
  Senior Vice President - Neurology
• Mike Romaniw,
  Executive Vice President - Systems & Operations
• Michael Atieh,
  Independent Chairman of the Board
• Dr. Peter S. Staats M.B.A., M.D.,
  Chief Medical Officer
• Eric J. Liebler,
  Sr. VP of Neurology
• Dr. Peter S. Staats,
  Chief Medical Officer
• Carrie Kochek,
  Sr. Director of HR
• Iain Strickland Ph.D.,
  VP of Global Sales & Strategy
• Jackie Dorsky,
  VP of Marketing
• Michael Romaniw,
  Exec. VP of Systems & Operations
• Julie Ann Goldstein,
  Director
• James L L Tullis,
  Director
• Nicholas Colucci,
  Director
• Global Health Innovation Fu...,
  10% owner
• Carrie Smith Cox,
  Director
• Ventures Ii, Llc Core,
  10% owner
• Francis R. Amato,
  Chief Executive Officer
• Peter S. Staats,
  Chief Medical Officer
• Glenn S. Vraniak,
  Chief Financial Officer
• Charles Steve Theofilos,
  
• Patricia Wilber,
  Director